# The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg

> **NCT03801538** · PHASE4 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Peginterferon Alfa
- **DRUG:** Nucleoside Analog (Substance)

## Key facts

- **NCT ID:** NCT03801538
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801538, "The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03801538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*